Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

Gut ◽

10.1136/gut.2010.219089 ◽

2010 ◽

Vol 59 (12) ◽

pp. 1694-1698 ◽

Author(s):

Rami Moucari ◽

Nicole Forestier ◽

Dominique Larrey ◽

Dominique Guyader ◽

Patrice Couzigou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Insulin Sensitivity ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Download Full-text

283 HCV PROTEASE INHIBITOR RESTORES INSULIN SENSITIVITY IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(10)60285-1 ◽

2010 ◽

Vol 52 ◽

pp. S118-S119

Author(s):

R. Moucari ◽

N. Forestier ◽

D. Larrey ◽

D. Guyader ◽

P. Couzigou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Insulin Sensitivity ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Hcv Protease ◽

Chronic Hepatitis C Patients

Download Full-text

Development of autoantibodies against “rings and rods”-associated IMPDH2 in chronic hepatitis C genotype 1 infection during protease inhibitor based triple therapy in a “real life” cohort

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1597391 ◽

2016 ◽

Vol 54 (12) ◽

pp. 1343-1404

Author(s):

W Dammermann ◽

S Polywka ◽

I Dettmann ◽

S Mindorf ◽

L Komorowski ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Download Full-text

294 Safety and antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, genotype 1, and liver cirrhosis

10.1016/s0270-9139(03)80337-3 ◽

2003 ◽

Vol 38 ◽

pp. 297-297 ◽

Author(s):

H WEDEMEYER ◽

A ERHARDT ◽

W SCHMIEGEL ◽

H HINRICHSEN ◽

R CHAVES ◽

...

Keyword(s):

Liver Cirrhosis ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Serine Protease ◽

Chronic Hepatitis C ◽

Oral Treatment ◽

Antiviral Effect ◽

Serine Protease Inhibitor ◽

Download Full-text

1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61108-8 ◽

2012 ◽

Vol 56 ◽

pp. S431-S432 ◽

Author(s):

J.-P. Bronowicki ◽

S. Pol ◽

P. Thuluvath ◽

D. Larrey ◽

C.T. Martorell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Treatment Naïve ◽

Peginterferon And Ribavirin ◽

Download Full-text

Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection

BMC Gastroenterology ◽

10.1186/1471-230x-14-87 ◽

2014 ◽

Vol 14 (1) ◽

Author(s):

Malte H Wehmeyer ◽

Friederike Eißing ◽

Sabine Jordan ◽

Claudia Röder ◽

Annette Hennigs ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Real Life ◽

Single Center ◽

Safety And Efficacy

Download Full-text

Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus

Nature Biotechnology ◽

10.1038/nbt.2020 ◽

2011 ◽

Vol 29 (11) ◽

pp. 993-1003 ◽

Author(s):

Ann D Kwong ◽

Robert S Kauffman ◽

Patricia Hurter ◽

Peter Mueller

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Chronic Hepatitis C Virus

Download Full-text

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE: Table 1.

Clinical Infectious Diseases ◽

10.1093/cid/civ722 ◽

2015 ◽

Vol 62 (1) ◽

pp. 32-36 ◽

Author(s):

Maria Buti ◽

Stuart C. Gordon ◽

Eli Zuckerman ◽

Eric Lawitz ◽

Jose L. Calleja ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2011.01528.x ◽

2011 ◽

Vol 19 (2) ◽

Author(s):

N. Hayashi ◽

T. Okanoue ◽

H. Tsubouchi ◽

J. Toyota ◽

K. Chayama ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Download Full-text

136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1

10.1016/s0270-9139(03)80179-9 ◽

2003 ◽

Vol 38 ◽

pp. 221-221 ◽

Author(s):

M REISER ◽

H HINRICHSEN ◽

Y BENHAMOU ◽

R SENTJENS ◽

H WEDEMEYER ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Serine Protease ◽

Chronic Hepatitis C ◽

Oral Treatment ◽

Antiviral Effect ◽

Serine Protease Inhibitor ◽

Download Full-text

Treating treatment-naïve Genotype 1 (G1) chronic Hepatitis C (CHC) patients with dual (Peginterferon/Ribavirin, P/R) or triple (P/R + Protease Inhibitor, PI) therapy in Hungary. An approach with limited financial resources

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1312386 ◽

2012 ◽

Vol 50 (05) ◽

Author(s):

B Hunyady ◽

M Makara ◽

J Gervain ◽

G Horváth ◽

F Szalay ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Financial Resources ◽

Triple P ◽

Treatment Naïve

Download Full-text